ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement for Patients With Aortic Regurgitation Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
1,250 participants
Mar 5, 2026
INTERVENTIONAL
Conditions
Summary
The overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transcatheter aortic valve replacement (TAVR) using J-VALVE Transfemoral Aortic Valve system
Surgical aortic valve replacement（SAVR）using commercially available surgical biological aortic valve replacement device
Locations(28)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07453407